BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 2849758)

  • 1. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.
    Hsiang YH; Liu LF
    Cancer Res; 1988 Apr; 48(7):1722-6. PubMed ID: 2832051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.
    Jaxel C; Capranico G; Kerrigan D; Kohn KW; Pommier Y
    J Biol Chem; 1991 Oct; 266(30):20418-23. PubMed ID: 1657924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
    Hsiang YH; Lihou MG; Liu LF
    Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.
    Tsao YP; Russo A; Nyamuswa G; Silber R; Liu LF
    Cancer Res; 1993 Dec; 53(24):5908-14. PubMed ID: 8261402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to camptothecin breaks leading and lagging strand simian virus 40 DNA replication forks.
    Shin CG; Snapka RM
    Biochem Biophys Res Commun; 1990 Apr; 168(1):135-40. PubMed ID: 2158312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.
    Capranico G; Kohn KW; Pommier Y
    Nucleic Acids Res; 1990 Nov; 18(22):6611-9. PubMed ID: 2174543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML; Hsu MT
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA.
    Edwards KA; Halligan BD; Davis JL; Nivera NL; Liu LF
    Nucleic Acids Res; 1982 Apr; 10(8):2565-76. PubMed ID: 6281736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopy.
    Feofanov AV; Baranov AV; Fleury F; Riou JF; Nabiev IR; Manfait M
    FEBS Lett; 1996 Nov; 396(2-3):289-92. PubMed ID: 8915005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of camptothecin on topoisomerase I catalysis.
    Christiansen K; Westergaard O
    Ann N Y Acad Sci; 1996 Dec; 803():50-9. PubMed ID: 8993500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
    Yang L; Rowe TC; Nelson EM; Liu LF
    Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of topoisomerase 1 with the transcribed region of the Drosophila HSP 70 heat shock gene.
    Kroeger PE; Rowe TC
    Nucleic Acids Res; 1989 Nov; 17(21):8495-509. PubMed ID: 2555773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.
    Tanizawa A; Kohn KW; Pommier Y
    Nucleic Acids Res; 1993 Nov; 21(22):5157-66. PubMed ID: 8255771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a camptothecin-resistant human DNA topoisomerase I in an in vitro system for Simian virus 40 DNA replication.
    Ishimi Y; Nishizawa M; Andoh T
    Eur J Biochem; 1991 Dec; 202(3):835-9. PubMed ID: 1662615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.
    Hertzberg RP; Caranfa MJ; Hecht SM
    Biochemistry; 1989 May; 28(11):4629-38. PubMed ID: 2548584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.
    Kjeldsen E; Mollerup S; Thomsen B; Bonven BJ; Bolund L; Westergaard O
    J Mol Biol; 1988 Jul; 202(2):333-42. PubMed ID: 2845097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J; Schedl P; Shenk T
    J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
    Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
    Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.